These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28714361)

  • 1. RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.
    Zhang J; Chen Z; Tang Z; Huang J; Hu X; He J
    Tumour Biol; 2017 Jul; 39(7):1010428317708546. PubMed ID: 28714361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?
    Qiao JJ; Chan TH; Qin YR; Chen L
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):865-8. PubMed ID: 24928581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
    Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
    Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
    Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
    Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.
    George CX; Samuel CE
    Virology; 2015 Nov; 485():363-70. PubMed ID: 26335850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA editing of
    Fu L; Qin YR; Ming XY; Zuo XB; Diao YW; Zhang LY; Ai J; Liu BL; Huang TX; Cao TT; Tan BB; Xiang D; Zeng CM; Gong J; Zhang Q; Dong SS; Chen J; Liu H; Wu JL; Qi RZ; Xie D; Wang LD; Guan XY
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4631-E4640. PubMed ID: 28533408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
    Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
    Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
    Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
    Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma.
    Caponio VCA; Troiano G; Botti G; Pedicillo MC; Lo Russo L; Mastrangelo F; Ciavarella D; Losito NS; Aquino G; Nocini R; Santoro R; Santoro A; Lo Muzio L; Pannone G
    J Oral Pathol Med; 2019 Feb; 48(2):108-114. PubMed ID: 30489667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
    Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
    Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
    J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in ADAR1 expression by exposure to cigarette smoke enhances susceptibility to oxidative stress.
    Takizawa M; Nakano M; Fukami T; Nakajima M
    Toxicol Lett; 2020 Oct; 331():22-32. PubMed ID: 32439581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure.
    Solomon O; Di Segni A; Cesarkas K; Porath HT; Marcu-Malina V; Mizrahi O; Stern-Ginossar N; Kol N; Farage-Barhom S; Glick-Saar E; Lerenthal Y; Levanon EY; Amariglio N; Unger R; Goldstein I; Eyal E; Rechavi G
    Nat Commun; 2017 Nov; 8(1):1440. PubMed ID: 29129909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
    Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
    Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1α-inhibiting factors.
    Ma CP; Liu H; Yi-Feng Chang I; Wang WC; Chen YT; Wu SM; Chen HW; Kuo YP; Shih CT; Li CY; Tan BC
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30948460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis.
    Vlachogiannis NI; Tual-Chalot S; Zormpas E; Bonini F; Ntouros PA; Pappa M; Bournia VK; Tektonidou MG; Souliotis VL; Mavragani CP; Stamatelopoulos K; Gatsiou A; Sfikakis PP; Stellos K
    J Autoimmun; 2021 Dec; 125():102755. PubMed ID: 34857436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation.
    Szymczak F; Cohen-Fultheim R; Thomaidou S; de Brachène AC; Castela A; Colli M; Marchetti P; Levanon E; Eizirik D; Zaldumbide A
    Front Endocrinol (Lausanne); 2022; 13():1058345. PubMed ID: 36518246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.